Výsledky vyhledávání

Association between treatment effects on disease progression end points and overall survival in clinical studies of patients with metastatic renal cell carcinoma

Autor: T E Delea, D Yc Heng, Anne Khuu, Denis Soulières, T Haas

Publikováno v: British Journal of Cancer

Background: The relationship between progression-free survival and time to progression (PFS/TTP) and overall survival (OS) has been demonstrated in a variety of solid tumours but not in metastatic renal cell carcinoma (mRCC). Methods: A systematic li

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22855d32cbc2a0c2651278b60932bc94
https://doi.org/10.1038/bjc.2012.367

Zobrazit plný text záznamu

Healthcare utilization and costs associated with skeletal-related events in prostate cancer patients with bone metastases

Autor: T E Delea, M W Saville, Karen Chung, M Hagiwara

Publikováno v: Prostate cancer and prostatic diseases. 16(1)

Patients with bone metastases secondary to prostate cancer are predisposed to skeletal-related events (SREs), including spinal cord compression, pathological fracture, surgery to bone and radiotherapy to bone. The objective of this study was to docum

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::051bba30526551725249fbe29f8f9c15
https://pubmed.ncbi.nlm.nih.gov/23146970

Zobrazit plný text záznamu

Health resource utilization (HRU) and cost associated with bone metastases (BMets) and skeletal related events (SREs) in patients (Pts) with prostate cancer (PC)

Autor: M. Hagiwara, Karen Chung, C. Atchison, T. E. Delea

Publikováno v: Journal of Clinical Oncology. 29:e16542-e16542

e16542 Background: This study describes HRU and cost associated with BMets and SREs in PC pts who have received hormonal therapy (HT). Methods: Retrospective study using the Thomson MedStat MarketS...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2fe26c3c47c032047570278ed5658e5b
https://doi.org/10.1200/jco.2011.29.15_suppl.e16542

Zobrazit plný text záznamu

Cost-effectiveness of letrozole (LET) versus anastrozole (ANA) in postmenopausal women (PMW) with hormone receptor-positive (HR+) early-stage breast cancer (EBC) based on indirect comparison of BIG 1-98 and ATAC

Autor: Amy Guo, S. C. Zelt, T. E. Delea, M. A. Lipsitz

Publikováno v: Journal of Clinical Oncology. 28:e11013-e11013

e11013 Background: BIG 1-98 and ATAC demonstrated that, in PMW with HR+ EBC, 5 y of initial adjuvant endocrine therapy (ET) with the aromatase inhibitors (AIs) LET or ANA is superior to tamoxifen (...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1199baa75c06e43a0ea15b5a4dc9bfa9
https://doi.org/10.1200/jco.2010.28.15_suppl.e11013

Zobrazit plný text záznamu

Association between treatment effects on disease progression (DP) endpoints and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)

Autor: J. F. Baladi, T. E. Delea, A. Khuu, J. Zheng, A. Kay

Publikováno v: Journal of Clinical Oncology. 27:5105-5105

5105 Background: Access to safe and effective novel therapies may be expedited if DP endpoints (progression-free survival [PFS], time to progression [TTP], or event-free survival) are established as valid surrogates for OS in pivotal studies in mRCC.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::67297052a331a95b23b803e22217c411
https://doi.org/10.1200/jco.2009.27.15_suppl.5105

Zobrazit plný text záznamu

Cost-effectiveness of HER-2 testing strategies to select women with metastatic breast cancer (MBC) for treatment with trastuzumab

Autor: G. Oster, T. E. Delea, A. Berger, P. Klein, G. Lieberman, V. E. Paton, A. Chawla

Publikováno v: Journal of Clinical Oncology. 22:768-768

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::48833d1ed7b956fa8fb7884710f191cb
https://doi.org/10.1200/jco.2004.22.90140.768

Zobrazit plný text záznamu

Impact of skeletal complications on total medical care costs in lung cancer patients with bone metastases

Autor: T. E. Delea, J. M. McKiernan, M. Liss, J. S. Edelsberg, J. Brandman, J. C. Sung, M. K. Raut, G. Oster

Publikováno v: Journal of Clinical Oncology. 22:6064-6064

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bb47fb3d9a1fb35c7af5318b48010d0c
https://doi.org/10.1200/jco.2004.22.90140.6064

Zobrazit plný text záznamu

Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks

Autor: G, Oster, D M, Huse, T E, Delea, D D, Savage, G A, Colditz

Publikováno v: Journal of the National Medical Association. 79(10)

The cost effectiveness of labetalol and propranolol in the treatment of black adults with mild to moderate hypertension was assessed using published reports from US clinical trials of these agents among such patients. Data from these studies suggest

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::88c3d635366e377a260f90a7222cc29a
https://pubmed.ncbi.nlm.nih.gov/3119865

Zobrazit plný text záznamu

Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking

Autor: G, Oster, D M, Huse, T E, Delea, G A, Colditz

Publikováno v: JAMA. 256(10)

A nicotine chewing gum has recently become available for use as an aid in giving up cigarette smoking. Although its efficacy has been demonstrated in clinic-based smoking cessation programs, its value in a primary care setting is uncertain. We examin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::806e3157d7501c2fb7e86ab2ca966d8b
https://pubmed.ncbi.nlm.nih.gov/3091857

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání